SANOFI

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56121
 
  
 
C07D HETEROCYCLIC COMPOUNDS 43911
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 15939
 
  
 
C07K PEPTIDES 8456
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 6437
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 639
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 34104
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2772
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 20186
 
  
 
2402 MEDICAL INSTRUMENTS, INSTRUMENTS AND TOOLS FOR LABORATORY USE1726

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0057,597 ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123Jul 20, 17Mar 01, 18[G01N, C07K]
2018/0050,160 Drug Delivery DeviceOct 09, 15Feb 22, 18[A61M]
2018/0050,161 Drug Delivery DeviceMar 11, 16Feb 22, 18[A61M]
2018/0030,156 ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USESJul 10, 17Feb 01, 18[C07K]
2018/0021,518 Trigger Mechanism and Drug Delivery Device herewithJan 29, 16Jan 25, 18[A61M]
2018/0022,814 SPECIFIC ANTI-CD38 ANTIBODIES FOR TREATING HUMAN CANCERSApr 05, 17Jan 25, 18[A61K, C07K]
2018/0008,707 STABLE LIQUID FORMULATION FOR MONOCLONAL ANTIBODIESFeb 12, 16Jan 11, 18[A61K, C07K]
2018/0008,781 Drug Delivery Device with a Drive MechanismDec 08, 15Jan 11, 18[A61M]
2018/0008,782 Method for Assembling a Drug Delivery Device and Drug Delivery DeviceDec 08, 15Jan 11, 18[A61M]
2017/0361,038 Assembly for a Drug Delivery DeviceJan 13, 16Dec 21, 17[A61M]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
D812740 Medicament injection deviceOct 28, 16Mar 13, 18[2402]
9908868 Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersOct 03, 16Mar 06, 18[A61K, C07D]
D812220 Injection deviceMar 27, 15Mar 06, 18[2402]
9895423 Stabilized pharmaceutical formulations of insulin aspartJan 08, 15Feb 20, 18[A61K]
9895424 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivativesJan 08, 15Feb 20, 18[A61K]
9896434 Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disordersApr 02, 15Feb 20, 18[A61K, C07D]
9889130 Substituted 3-benzofuranyl-indol-2-one-3-acetamididopiperazine derivatives, preparation thereof, and therapeutic use thereofNov 10, 16Feb 13, 18[A61K, C07D]
9884860 Fused pyrroledicarboxamides and their use as pharmaceuticalsFeb 11, 16Feb 06, 18[A61K, C07D]
9884898 Proteins specific for pyoverdine and pyochelinMay 23, 17Feb 06, 18[A61K, C07K]
9878990 Benzylhydroxide derivatives, preparation thereof and therapeutic use thereofOct 29, 15Jan 30, 18[A61K, C07D, A61P]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0166,548 Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticalsAbandonedMar 08, 17Jun 15, 17[C07D]
2017/0022,260 EXENDIN-4 PEPTIDE ANALOGUES AS DUAL GLP-1/GLUCAGON RECEPTOR AGONISTSAbandonedDec 12, 14Jan 26, 17[A61K, C07K]
2016/0338,989 SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING BENZOFURAN DERIVATIVESAbandonedMay 06, 16Nov 24, 16[A61K]
2016/0310,521 POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTSAbandonedApr 21, 16Oct 27, 16[A61K, C08B]
2016/0272,606 PROCESS FOR PREPARATION OF DRONEDARONE BY OXIDATION OF A HYDROXYL GROUPAbandonedJun 01, 16Sep 22, 16[C07D]
2016/0228,516 Long-Acting Formulations of InsulinAbandonedApr 20, 16Aug 11, 16[A61K]
2016/0220,643 EXENDIN-4 DERIVATIVES AS DUAL GLP1/GLUCAGON AGONISTSAbandonedApr 15, 16Aug 04, 16[A61K]
2016/0193,192 EXTRACELLULAR ALLOSTERIC INHIBITOR BINDING DOMAIN FROM A TYROSINE KINASE RECEPTORAbandonedNov 30, 15Jul 07, 16[A61K]
2016/0175,304 N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALSAbandonedNov 23, 15Jun 23, 16[A61K]
2016/0066,550 Animal Model Expressing Luciferase under Control of the Myelin Basic Protein Promoter (MBP-luci) and Use of the Model for Bioluminescence In Vivo ImagingAbandonedJul 16, 15Mar 10, 16[A01K]
2016/0030,438 ANTI-TUMORAL COMPOSITION COMPRISING A PI3KBETA INHIBITOR AND A RAF INHIBITOR, TO OVERCOME CANCER CELLS RESISTANCEAbandonedMar 14, 14Feb 04, 16[A61K, G01N]
2016/0030,440 ANTI-TUMORAL COMPOSITION COMPRISING A PI3KBETA-SELECTIVE INHIBITOR AND A PI3KALPHA-SELECTIVE INHIBITORAbandonedApr 03, 14Feb 04, 16[A61K]
2016/0022,813 COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIBAbandonedMar 13, 14Jan 28, 16[A61K]
2015/0274,703 1H-Indole-3-Carboxamide Derivatives And Use Thereof As P2Y12 AntagonistsAbandonedOct 24, 13Oct 01, 15[C07D]
2015/0274,787 METHOD FOR RECOMBINANT PRODUCTION OF LABYRINTHOPEPTINS AND FUNCTIONAL DERIVATIVES THEREOFAbandonedDec 19, 12Oct 01, 15[C07K]
2015/0231,210 Pharmaceutical Composition for Treating a Metabolic SyndromeAbandonedFeb 20, 15Aug 20, 15[A61K]
2015/0225,479 Anti-IL-4/Anti-IL-13 Bispecific Antibody/Polyglutamate FormulationsAbandonedFeb 11, 15Aug 13, 15[A61K, C07K]
2015/0216,795 ARTICLE OF MANUFACTURE COMPRISING AFLIBERCEPT OR ZIV-AFLIBERCEPTAbandonedFeb 02, 15Aug 06, 15[A61K, B65D]
2015/0208,623 TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOFAbandonedFeb 04, 15Jul 30, 15[C12N, A01K, G01N]
2015/0210,729 MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOFAbandonedMar 16, 15Jul 30, 15[C07H]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.